Effects of curcumin and Ginkgo biloba on matrix metalloproteinases gene expression and other biomarkers of inflammatory bowel disease

Journal of Physiology and Biochemistry

Volumn 68, Issue 4, 2012, Pages 529-539

  Motawi, Tarek Kamal ^a   Rizk, Sherine Maher ^a   Shehata, Ahmed Hassan ^a  

^a CAIRO UNIVERSITY   (Egypt)

Author keywords

Curcumin; Gene expression; Ginkgo; IBD; Matrix metalloproteinases

Indexed keywords

CERULOPLASMIN; CURCUMIN; GINKGO BILOBA EXTRACT; HYDROXYPROLINE; MATRIX METALLOPROTEINASE; MYELOPEROXIDASE; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CURCUMA LONGA; DISEASE MARKER; ENTERITIS; ENZYME ACTIVITY; GENE EXPRESSION; GINKGO BILOBA; HISTOPATHOLOGY; MALE; NONHUMAN; THERAPY EFFECT;

ANIMALS; BIOLOGICAL MARKERS; CERULOPLASMIN; COLON; CURCUMIN; DRUGS, CHINESE HERBAL; GENE EXPRESSION; GINKGO BILOBA; HYDROXYPROLINE; INFLAMMATORY BOWEL DISEASES; MALE; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 3; NITRIC OXIDE; PEROXIDASE; RATS; RATS, WISTAR; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TUMOR NECROSIS FACTOR-ALPHA;

GINKGO BILOBA; RATTUS;

EID: 84871259508     PISSN: 11387548     EISSN: 18778755     Source Type: Journal    
DOI: 10.1007/s13105-012-0168-9     Document Type: Article

References (56)

1. Abdel-Salam OM, Baiuomy AR, El-batran S, Arbid MS (2004) Evaluation of the anti-inflammatory, antinociceptive and gastric effects of Ginkgo biloba in the rat. Pharmacol Res 49:133-142
2. Ackerman Z, Karmeli F, Cohen P, Rachmilewitz D (2003) Experimental colitis in rats with portal hypertension and liver disease. Inflamm Bowel Dis 9:18-24
3. Aggarwal BB, Sundaram C, Malani N, Ichikawa H (2007) Curcumin: the Indian solid gold. Adv Exp Med Biol 595:1- 75
4. Arafa HM (2005) Curcumin attenuates diet-induced hypercholesterolemia in rats. Med Sci Monit 11:BR228-234
5. Arafa HM, Hemeida RA, El-Bahrawy AI, Hamada FM (2009) Prophylactic role of curcumin in dextran sulfate sodium (DSS)-induced ulcerative colitis murine model. Food Chem Toxicol 47:1311-1317
6. Biddlestone L, Corbett AD, Dolan S (2007) Oral administration of Ginkgo biloba extract, EGb-761 inhibits thermal hyperalgesia in rodent models of inflammatory and postsurgical pain. Br J Pharmacol 151:285-291
7. Black RA, Rauch CT, Kozlosky CJ, Peschon JJ, Slack JL, Wolfson MF, Castner BJ, Stocking KL, Reddy P, Srinivasan S, Nelson N, Boiani N, Schooley KA, Gerhart M, Davis R, Fitzner JN, Johnson RS, Paxton RJ, March CJ, Cerretti DP (1997) A metalloproteinase disintegrin that releases tumournecrosis factor-alpha from cells. Nature 385:729-733
8. Bobek P, Nosalova V, Cerna S (2001) Effect of pleuran (beta-glucan from Pleurotus ostreatus) in diet or drinking fluid on colitis in rats. Nahrung 45:360-363
9. Bradley PP, Priebat DA, Christensen RD, Rothstein G (1982) Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol 78:206-209
10. Bridi R, Crossetti FP, Steffen VM, Henriques AT (2001) The antioxidant activity of standardized extract of Ginkgo biloba (EGb 761) in rats. Phytother Res 15:449-451
11. Camacho-Barquero L, Villegas I, Sanchez-Calvo JM, Talero E, Sanchez-Fidalgo S, Motilva V, Alarcon de la Lastra C (2007) Curcumin, a Curcuma longa constituent, acts on MAPK p38 pathway modulating COX-2 and iNOS expression in chronic experimental colitis. Int Immunopharmacol 7:333-342
12. Chan MM, Ho CT, Huang HI (1995) Effects of three dietary phytochemicals from tea, rosemary and turmeric on inflammation-induced nitrite production. Cancer Lett 96:23-29
13. De Ponti F, Tonini M (2001) Irritable bowel syndrome: new agents targeting serotonin receptor subtypes. Drugs 61:317- 332
14. Frisch SM, Ruley HE (1987) Transcription from the stromelysin promoter is induced by interleukin-1 and repressed by dexamethasone. J Biol Chem 262:16300-16304
15. Hagar HH, El-Medany A, El-Eter E, Arafa M (2007) Ameliorative effect of pyrrolidinedithiocarbamate on acetic acidinduced colitis in rats. Eur J Pharmacol 554:69-77
16. Hartz PH (1947) Simultaneous histologic fixation and gross demonstration of calcification. Am J Clin Pathol 17:750
17. Hussain SP, He P, Subleski J, Hofseth LJ, Trivers GE, Mechanic L, Hofseth AB, Bernard M, Schwank J, Nguyen G, Mathe E, Djurickovic D, Haines D, Weiss J, Back T, Gruys E, Laubach VE, Wiltrout RH, Harris CC (2008) Nitric oxide is a key component in inflammationaccelerated tumorigenesis. Cancer Res 68:7130-7136
18. Ince AT, Kayadibi H, Soylu A, Ovunc O, Gultepe M, Toros AB, Yasar B, Kendir T, Abut E (2008) Serum copper, ceruloplasmin and 24-h urine copper evaluations in celiac patients. Dig Dis Sci 53:1564-1572
19. Ishiguro Y (1999) Mucosal proinflammatory cytokine production correlates with endoscopic activity of ulcerative colitis. J Gastroenterol 34:66-74
20. Jacob A, Wu R, Zhou M, Wang P (2007) Mechanism of the anti-inflammatory effect of Curcumin: PPAR-gamma activation. PPAR Res 2007:89369
21. Jiang H, Deng CS, Zhang M, Xia J (2006) Curcuminattenuated trinitrobenzene sulphonic acid induces chronic colitis by inhibiting expression of cyclooxygenase-2. World J Gastroenterol 12:3848-3853
22. Kaulfersch W, Fiocchi C, Waldmann TA (1988) Polyclonal nature of the intestinal mucosal lymphocyte populations in inflammatory bowel disease. A molecular genetic evaluation of the immunoglobulin and T-cell antigen receptors. Gastroenterology 95:364-370
23. Khan I, Hussein SM, Oriowo MA (2002) Studies on the expression and function of beta-3-adrenoceptors in the colon of rats with acetic acid-induced colitis. Pharmacology 64:98-105
24. Kotakadi VS, Jin Y, Hofseth AB, Ying L, Cui X, Volate S, Chumanevich A, Wood PA, Price RL, McNeal A, Singh UP, Singh NP, Nagarkatti M, Nagarkatti PS, Matesic LE, Auclair K, Wargovich MJ, Hofseth LJ (2008) Ginkgo biloba extract EGb 761 has anti-inflammatory properties and ameliorates colitis in mice by driving effector T cell apoptosis. Carcinogenesis 29:1799-1806
25. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275
26. MacNaul KL, Chartrain N, Lark M, Tocci MJ, Hutchinson NI (1990) Discoordinate expression of stromelysin, collagenase, and tissue inhibitor of metalloproteinases-1 in rheumatoid human synovial fibroblasts. Synergistic effects of interleukin-1 and tumor necrosis factor-alpha on stromelysin expression. J Biol Chem 265:17238-17245
27. Martin AR, Villegas I, La Casa C, Alarcon de la Lastra C (2003) The cyclo-oxygenase-2 inhibitor, rofecoxib, attenuates mucosal damage due to colitis induced by trinitrobenzene sulphonic acid in rats. Eur J Pharmacol 481:281-291
28. Mei Q, Xu JM, Xiang L, Hu YM, Hu XP, Xu ZW (2005) Change of nitric oxide in experimental colitis and its inhibition by melatonin in vivo and in vitro. Postgrad Med J 81:667-672
29. Miranda KM, Espey MG, Wink DA (2001) A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric Oxide 5:62-71
30. Morris GP, Beck PL, Herridge MS, Depew WT, Szewczuk MR, Wallace JL (1989) Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 96:795-803
31. Mukhopadhyay A, Basu N, Ghatak N, Gujral PK (1982) Anti-inflammatory and irritant activities of curcumin analogues in rats. Agents Actions 12:508-515
32. Mustafa A, El-Medany A, Hagar HH, El-Medany G (2006) Ginkgo biloba attenuates mucosal damage in a rat model of ulcerative colitis. Pharmacol Res 53:324-330
33. Naito Y, Yoshikawa T (2005) Role ofmatrixmetalloproteinases in inflammatory bowel disease. Mol Asp Med 26:379-390
34. Neuman RE (1949) The amino acid composition of gelatins, collagens and elastins from different sources. Arch Biochem 24:289-298
35. Nitta M, Hirata I, Toshina K, Murano M, Maemura K, Hamamoto N, Sasaki S, Yamauchi H, Katsu K (2002) Expression of the EP4 prostaglandin E2 receptor subtype with rat dextran sodium sulphate colitis: colitis suppression by a selective agonist, ONO-AE1-329. Scand J Immunol 56:66-75
36. Otamiri T, Tagesson C (1989) Ginkgo biloba extract prevents mucosal damage associated with small-intestinal ischaemia. Scand J Gastroenterol 24:666-670
37. Pehlivan M, Dalbeler Y, Hazinedaroglu S, Arikan Y, Erkek AB, Gunal O, Turkcapar N, Turkcapar AG (2002) An assessment of the effect of Ginkgo biloba EGb 761 on ischemia reperfusion injury of intestine. Hepatogastroenterology 49:201-204
38. Pincemail J, Thirion A, Dupuis M, Braquet P, Drieu K, Deby C (1987) Ginkgo biloba extract inhibits oxygen species production generated by phorbol myristate acetate stimulated human leukocytes. Experientia 43:181-184
39. Rachmilewitz D, Karmeli F, Okon E, Bursztyn M (1995) Experimental colitis is ameliorated by inhibition of nitric oxide synthase activity. Gut 37:247-255
40. Rogler G, Andus T (1998) Cytokines in inflammatory bowel disease. World J Surg 22:382-389
41. Sartor RB (1997) Pathogenesis and immune mechanisms of chronic inflammatory bowel diseases. Am J Gastroenterol 92:5S-11S
42. Schosinsky KH, Lehmann HP, Beeler MF (1974) Measurement of ceruloplasmin from its oxidase activity in serum by use of o-dianisidine dihydrochloride. Clin Chem 20:1556- 1563
43. Shanahan F (2001) Inflammatory bowel disease: immunodiagnostics, immunotherapeutics, and ecotherapeutics. Gastroenterology 120:622-635
44. Sharon P, Stenson WF (1984) Enhanced synthesis of leukotriene B4 by colonic mucosa in inflammatory bowel disease. Gastroenterology 86:453-460
45. Sugimoto K, Hanai H, Tozawa K, Aoshi T, Uchijima M, Nagata T, Koide Y (2002) Curcumin prevents and ameliorates trinitrobenzene sulfonic acid-induced colitis in mice. Gastroenterology 123:1912-1922
46. Talero E, Sanchez-Fidalgo S, Ramon Calvo J, Motilva V (2006) Galanin in the trinitrobenzene sulfonic acid rat model of experimental colitis. Int Immunopharmacol 6:1404-1412
47. Ukil A, Maity S, Karmakar S, Datta N, Vedasiromoni JR, Das PK (2003) Curcumin, the major component of food flavour turmeric, reduces mucosal injury in trinitrobenzene sulphonic acid-induced colitis. Br J Pharmacol 139:209-218
48. Van Crombruggen K, Van Nassauw L, Demetter P, Cuvelier C, Timmermans JP, Lefebvre RA (2008) Influence of soluble guanylate cyclase inhibition on inflammation and motility disturbances in DSS-induced colitis. Eur J Pharmacol 579:337-349
49. Villegas I, Alarcon de la Lastra C, Orjales A, La Casa C (2003) A new flavonoid derivative, dosmalfate, attenuates the development of dextran sulphate sodium-induced colitis in mice. Int Immunopharmacol 3:1731-1741
50. von Lampe B, Barthel B, Coupland SE, Riecken EO, Rosewicz S (2000) Differential expression of matrix metalloproteinases and their tissue inhibitors in colon mucosa of patients with inflammatory bowel disease. Gut 47:63-73
51. Wang YD, Mao JW (2007) Expression of matrix metalloproteinase-1 and tumor necrosis factor-alpha in ulcerative colitis. World J Gastroenterol 13:5926-5932
52. Wang YD, Yan PY (2006) Expression of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase- 1 in ulcerative colitis. World J Gastroenterol 12:6050-6053
53. Woessner JF Jr (1991) Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 5:2145-2154
54. Yamada T, Zimmerman BJ, Specian RD, Grisham MB (1991) Role of neutrophils in acetic acid-induced colitis in rats. Inflammation 15:399-411
55. Yoshikawa T, Naito Y, Kondo M (1999) Ginkgo biloba leaf extract: review of biological actions and clinical applications. Antioxid Redox Signal 1:469-480
56. Zeybek N, Gorgulu S, Yagci G, Serdar M, Simsek A, Kaymakcioglu N, Deveci S, Ozcelik H, Tufan T (2003) The effects of gingko biloba extract (EGb 761) on experimental acute pancreatitis. J Surg Res 115:286- 293